Feature

Massachusetts tops state vaccination rankings


 

Vaccination policy in the United States is set largely at the state level, and no state does a better job at vaccinating than Massachusetts, according to a new analysis from personal finance website WalletHub.

The Bay State’s top finish in the “children and teenagers immunization rates” category moved it ahead of Vermont in the overall rankings, which had the highest score in each of the other two broad categories – “adult and elderly vaccination rates” and “immunization uptake disparities and influencing factors” – but only finished 15th in child/teen immunization, Wallethub reported.

The state that ranked 51st in child/teen immunization – Mississippi – also finished 51st overall, behind every other state and Washington, D.C. The rest of the bottom five consisted of Texas (50th); Florida (49th), which ranked last in the adult/elderly category; Georgia (48th); and Indiana (47th). New Mexico, however, managed to show that last is not always least by earning a mid-pack overall rank of 30 despite its last-place showing in the disparities/influencing factors category, the WalletHub analysis showed.

Scores for the three broad categories were determined using 18 relevant metrics, including influenza vaccination rate in children aged 6 months to 17 years (1st, Rhode Island; 51st, Wyoming), share of adults aged 60 years and older with zoster vaccination (1st, Vermont; 51st, Mississippi), and share of population without health insurance coverage (1st, Massachusetts; 51st, Texas), WalletHub said.

“Each state should tailor its vaccines policy to its need, with an understanding that those needs may change,” Dorit Rubinstein Reiss of the University of California Hastings College of the Law, San Francisco, told WalletHub. When parents refuse to have their children vaccinated, it’s important to remember that “the state is not denying these children schooling. It is requiring that they be protected from disease first.”

Recommended Reading

AAN guideline encourages vaccinations for MS patients
MDedge Infectious Disease
MenB vaccination coverage higher in those receiving MenB-4C
MDedge Infectious Disease
Decision making regarding vaccines varies among accepters, deniers, partial accepters
MDedge Infectious Disease
Measles outbreak in New York City has ended
MDedge Infectious Disease
Measles cases continue to decline
MDedge Infectious Disease
New engineered HIV-1 vaccine candidate shows improved immunogenicity in early trial
MDedge Infectious Disease
Australia’s rotavirus outbreak wasn’t caused by vaccine effectiveness decline
MDedge Infectious Disease
Taking vaccines to the next level via mucosal immunity
MDedge Infectious Disease
FDA approves first live vaccine for smallpox, monkeypox prevention
MDedge Infectious Disease
Zostavax proves safe, effective in patients with nonactive SLE
MDedge Infectious Disease